BridgeBio Pharma BBIO
NASDAQ BBIO
$66.16 +0.19 (+0.29%)
As of: Sep 30, 2026 · 12:16 PM EDT

BridgeBio Pharma (BBIO) Operating Margin (2020 - 2026)

Updated

BridgeBio Pharma's Operating Margin came in at -43.94% for Q2 2026, up 77.50 percentage points from -121.45% a year earlier and up 10.53 percentage points from the prior quarter.

Analysis

BridgeBio Pharma (BBIO) Operating Margin (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, BridgeBio Pharma reported Operating Margin of -69.81%, up 208.56 percentage points year-over-year; for FY2025, it came in at -104.25%, up 162.97 percentage points from FY2024.

  • Operating Margin carries a five-year change of +5647.74 percentage points (FY2020 to FY2025).
  • Going back by year, Operating Margin was -267.22% in FY2024 (+6261.53 pp), -6528.75% in FY2023 (-5869.11 pp), -659.65% in FY2022 (+167.47 pp) and -827.12% in FY2021 (+4924.88 pp).
  • The Q2 2026 figure represents the highest quarterly Operating Margin since Q1 2024.
  • Year-over-year, Operating Margin has increased for five consecutive quarters, with an average year-over-year change of +2726.14 percentage points over the last eight quarters.
  • The fastest year-over-year change in Operating Margin over five years came in Q4 2021 (a gain of 103213.96 percentage points), and the weakest in Q3 2022 (a drop of 31822.06 percentage points).
  • Business Quant data shows BBIO's Operating Margin at -54.47% (Q1 2026), -90.52% (Q4 2025) and -120.30% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 BridgeBio Pharma 13.01 Bn 10.12 Bn 228.63 Mn -43.94%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -43.94%
Mar 31, 2026 -54.47%
Dec 31, 2025 -90.52%
Sep 30, 2025 -120.30%
Jun 30, 2025 -121.45%
Mar 31, 2025 -89.49%
Dec 31, 2024 -3,842.69%
Sep 30, 2024 -7,018.67%
Jun 30, 2024 -8,096.82%
Mar 31, 2024 0.16%
Dec 31, 2023 -10,167.11%
Sep 30, 2023 -3,854.61%
Jun 30, 2023 -8,903.05%
Mar 31, 2023 -6,909.26%
Dec 31, 2022 -6,910.80%
Sep 30, 2022 -38,200.00%
Jun 30, 2022 -108.72%
Mar 31, 2022 -10,252.54%
Dec 31, 2021 -1,285.22%
Sep 30, 2021 -6,377.94%
API Access

BridgeBio Pharma Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=BBIO&period=max&api_key=YOUR_API_KEY